Inovio Pharmaceuticals, Inc.
(NASDAQ : INO)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
INOInovio Pharmaceuticals, Inc. 8.72%21.456.3%$1116.52m
MDTMedtronic Plc 0.93%93.180.6%$608.53m
ABTAbbott Laboratories 0.66%92.240.8%$564.00m
TMOThermo Fisher Scientific, Inc. 1.69%365.851.0%$548.96m
DXCMDexCom, Inc. 1.78%407.358.2%$544.50m
BDXBecton, Dickinson & Co. 1.42%244.951.0%$513.39m
DHRDanaher Corp. 1.42%179.680.7%$458.12m
BSXBoston Scientific Corp. 0.31%35.391.0%$435.72m
ISRGIntuitive Surgical, Inc. 0.86%580.482.4%$376.03m
QDELQuidel Corp. 2.85%227.047.7%$372.79m
SYKStryker Corp. 0.11%184.051.3%$326.37m
BAXBaxter International, Inc. -0.13%87.201.8%$280.06m
ALGNAlign Technology, Inc. 2.22%279.936.4%$275.80m
EWEdwards Lifesciences Corp. 0.33%69.230.4%$224.11m
ZBHZimmer Biomet Holdings, Inc. 1.08%120.631.7%$213.14m

Company Profile

Inovio Pharmaceuticals, Inc. is a late-stage biotechnology company. It engages in the discovery, development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system's tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.